Market Trends of Global Cell Sorting Industry
This section covers the major market trends shaping the Cell Sorting Market according to our research experts:
Fluorescence-based Droplet Cell Sorting (FACS) is Expected to be the Largest Growing Segment in the Cell Sorting Market
The fluorescence-based droplet cell sorting segment is expected to grow during the forecast period due to it being a highly accurate and precise sorting method. It is essential in numerous biological assays requiring high-throughput analysis and sorting of single cells. The gold standard technology for this purpose is fluorescence-activated cell sorting (FACS).
It provides a method of filtering a mixture of living cells in two or more vessels, one cell at a time, based on light scattering light and fluorescent features of each cell. It is a useful scientific tool, as it provides a fast, purposeful, and balanced recording of fluorescent signals from individual cells as well as the body classification of specific cells of interest.
FACS is thus anticipated to be the segment driving the growth of the cell sorting market during the forecast period, owing to its accuracy and increasing applications. In addition, it offers higher purity and recovery of cells as compared to other methods, though the cells are lost due to mortality.
Moreover, the growing incidence of diseases like HIV and cancers is increasing the demand for these devices. The International Agency for Research on Cancer 2020 estimates that worldwide, one person in 5 develops cancer at some point in life, and 1 in 8 men and 1 in 11 women die from the disease. These new estimates showed that more than 50 million people live within five years of a previous cancer diagnosis for the year 2020. The number of older people worldwide and the economic and economic pressures remain among the factors contributing to this increase. The growing population of patients needing diagnosis is increasing the segment growth.
North America is Found Leading the Cell Sorting Market
North America has dominated the market due to the high investments in the pharmaceutical and biotechnology industries and the increasing adoption of this technique in cancer research, as well as the development of new therapeutics in countries such as the United States.
In addition, the rising incidence of cancer and other infectious diseases in the country drives regional growth. According to the Centers for Disease Control and Prevention, the number of visits to physician offices with infectious and parasitic diseases as the primary diagnosis was 15.5 million for the year 2018 in the country. The increasing rates of cancer and diseases that require cell sorting and the increasing healthcare expenditure in the country boost the market growth in the region.
The cell sorting market's growth in these regions can be attributed to advanced research infrastructures, significant health care spending, and increase government funding for research. According to Patented Medicine Prices Review Board - Annual Report 2018, the pharma expenditure in Canada increased from CAD 0.79 million in 2014 to CAD 0.89 million in 2018. The increase in fundings and the rising prevalence of chronic diseases boost the market growth in the region.
